Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01160926
What this trial is testing

Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial

Who this might be right for
Rectal Cancer
The Christie NHS Foundation Trust 31
Testing effectiveness (Phase 2)UnknownNCT00744315
What this trial is testing

Induced Angiogenesis by Genic Therapy in Advanced Ischemic Cardiomyopathy

Who this might be right for
Ischemic Cardiopathy
Instituto de Cardiologia do Rio Grande do Sul 20
Large-scale testing (Phase 3)UnknownNCT00501917
What this trial is testing

MAGIC Cell-5-Combicytokine Trial

Who this might be right for
Acute Myocardial Infarction
Seoul National University Hospital 116
Testing effectiveness (Phase 2)UnknownNCT04670913
What this trial is testing

Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy

Who this might be right for
Advanced Non Squamous NSCLC
Junling Li 30
Very early researchUnknownNCT01542073
What this trial is testing

68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Myocardial Infarction

Who this might be right for
Coronary Artery Disease
Peking Union Medical College Hospital 50
Not applicableStudy completedNCT07530341
What this trial is testing

Ketogenic Diet in Women With Lipedema

Who this might be right for
LipedemaOverweight and Obesity
Wroclaw Medical University 121
Not applicableStudy completedNCT00923780
What this trial is testing

Evaluation of Blood Vessel Formation in Endocrine Tumors

Who this might be right for
Lesions
National Cancer Institute (NCI) 400
Testing effectiveness (Phase 2)Study completedNCT00036569
What this trial is testing

A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas

Who this might be right for
Diffuse Intrinsic Pontine Glioma
National Cancer Institute (NCI) 32
Not applicableStudy completedNCT02581098
What this trial is testing

MiR-200b & miR-21 in Diabetic Wounds

Who this might be right for
Diabetes MellitusFoot UlcerUlcer+3 more
Indiana University 98
Not applicableUnknownNCT02671864
What this trial is testing

Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 7,200
Early research (Phase 1)UnknownNCT03050411
What this trial is testing

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Peking University Third Hospital 30
Not applicableUnknownNCT03991871
What this trial is testing

HARapan kiTa ECP (External Counter Pulsation) Study HARTEC Study

Who this might be right for
Cardiac RehabilitationAngiogenesisRefractory Angina
National Cardiovascular Center Harapan Kita Hospital Indonesia 50
Not applicableStudy completedNCT05009407
What this trial is testing

CD160 Expression in Corneal Vessels

Who this might be right for
Corneal Graft RejectionCD160Angiogenesis+1 more
CHU de Reims 43
Testing effectiveness (Phase 2)UnknownNCT05460195
What this trial is testing

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Who this might be right for
Non-small Cell Lung CancerMinimal Residual DiseaseImmunotherapy+1 more
Shanghai Chest Hospital 42
Not applicableUnknownNCT05301465
What this trial is testing

Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab.

Who this might be right for
Gastric Cancer Stage IV
University of Pisa 50
Testing effectiveness (Phase 2)Ended earlyNCT03387514
What this trial is testing

Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies

Who this might be right for
Renal Cell Carcinoma
University of Wisconsin, Madison 5
Testing effectiveness (Phase 2)UnknownNCT03742193
What this trial is testing

Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy

Who this might be right for
OsteosarcomaPulmonary MetastasesApatinib
Ruijin Hospital 43
Testing effectiveness (Phase 2)Study completedNCT00244764
What this trial is testing

GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 225
Not applicableEnded earlyNCT00657098
What this trial is testing

Side Effects of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) Directed Therapy

Who this might be right for
Metastatic Malignancies
University Medical Center Groningen 73
Testing effectiveness (Phase 2)Ended earlyNCT00280007
What this trial is testing

Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Medical University of Vienna 32
Next Page